Literature DB >> 18413654

FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies.

Y L Woo1, J Sterling, R Crawford, S H van der Burg, N Coleman, M Stanley.   

Abstract

Since its original description, there has been a substantial output of publications related to the FOXP3 gene. The FOXP3 protein, a member of the forkhead/winged-helix family of transcriptional regulators is a nuclear product and is not expressed in the cell cytoplasm or on the cell surface. Expression of this single transcription factor causes a developmental switch in naïve T cells to a suppressor cell phenotype, more commonly referred to as regulatory T cells (Tregs). Tregs have been intensively studied in various autoimmune diseases, infections and different cancers. An increasing choice of commercially available monoclonal antibodies targeting FOXP3 is now available. This report describes the experience of using two commonly used monoclonal FOXP3 antibodies on formalin-fixed paraffin-embedded sections of different organs, including the cervix and vulva. The antibodies targeting different FOXP3 epitopes unexpectedly resulted in significantly different staining patterns. This phenomenon has not been previously reported and is likely to be an important observation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413654     DOI: 10.1136/jcp.2008.056200

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

Review 1.  FOXP3 as an X-linked tumor suppressor.

Authors:  Lizhong Wang; Runhua Liu; Mark Ribick; Pan Zheng; Yang Liu
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

2.  Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence.

Authors:  José Vassallo; André Fellipe Freitas Rodrigues; Antonio Hugo J F M Campos; Rafael Malagoli Rocha; Isabela Werneck da Cunha; Stênio Cássio Zequi; Gustavo Cardoso Guimarães; Francisco Paulo da Fonseca; Ademar Lopes; Antonio Cubilla; Fernando Augusto Soares
Journal:  Tumour Biol       Date:  2015-01-05

3.  VEGFR-2 expression in human melanoma: revised assessment.

Authors:  Kerrington R Molhoek; Gulsun Erdag; J K Rasamny; Cheryl Murphy; Donna Deacon; James W Patterson; Craig L Slingluff; David L Brautigan
Journal:  Int J Cancer       Date:  2011-05-05       Impact factor: 7.396

4.  FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.

Authors:  BeeShin Tan; Matthew Anaka; Siddhartha Deb; Claudia Freyer; Lisa M Ebert; Anderly C Chueh; Sheren Al-Obaidi; Andreas Behren; Aparna Jayachandran; Jonathan Cebon; Weisan Chen; John M Mariadason
Journal:  Oncotarget       Date:  2014-01-15

5.  Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis.

Authors:  Tamara R Litwin; Sarah R Irvin; Rebecca L Chornock; Vikrant V Sahasrabuddhe; Margaret Stanley; Nicolas Wentzensen
Journal:  Br J Cancer       Date:  2020-12-01       Impact factor: 7.640

6.  Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

Authors:  Katy Milne; Martin Köbel; Steven E Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

7.  Regulatory T cells in colorectal cancer: from biology to prognostic relevance.

Authors:  Dimitrios Mougiakakos
Journal:  Cancers (Basel)       Date:  2011-03-29       Impact factor: 6.639

8.  FOXP3 subcellular localization predicts recurrence in oral squamous cell carcinoma.

Authors:  Donald T Weed; Gail Walker; Adriana C De La Fuente; Ronen Nazarian; Jennifer L Vella; Carmen R Gomez-Fernandez; Paolo Serafini
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.